These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15733071)

  • 1. Postprandial changes in LDL phenotypes in patients with myocardial infarction.
    Koba S; Tsunoda F; Hirano T; Iso Y; Suzuki H; Geshi E; Katagiri T
    Eur J Clin Invest; 2005 Mar; 35(3):171-9. PubMed ID: 15733071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-density lipoproteins generated during an oral fat load in mild hypertriglyceridemic and healthy subjects are smaller, denser, and have an increased low-density lipoprotein receptor binding affinity.
    Noto D; Rizzo M; Barbagallo CM; Cefalù AB; Verde AL; Fayer F; Notarbartolo A; Averna MR
    Metabolism; 2006 Oct; 55(10):1308-16. PubMed ID: 16979400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between small dense low-density lipoprotein and postprandial accumulation of triglyceride-rich remnant-like particles in normotriglyceridemic patients with myocardial infarction.
    Tsunoda F; Koba S; Hirano T; Ban Y; Iso Y; Suzuki H; Geshi E; Katagiri T
    Circ J; 2004 Dec; 68(12):1165-72. PubMed ID: 15564701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of postprandial lipaemia on low-density lipoprotein (LDL) size and oxidized LDL in patients with coronary artery disease.
    Granér M; Kahri J; Nakano T; Sarna SJ; Nieminen MS; Syvänne M; Taskinen MR
    Eur J Clin Invest; 2006 Nov; 36(11):764-70. PubMed ID: 17032343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low density lipoprotein particle size phenotyping in healthy persons and patients with myocardial infarction.
    Alabakovska SB; Labudović DD; Tosheska KN; Todorova BB
    Croat Med J; 2002 Jun; 43(3):290-5. PubMed ID: 12035134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A.
    Superko HR; Berneis KK; Williams PT; Rizzo M; Wood PD
    Am J Cardiol; 2005 Nov; 96(9):1266-72. PubMed ID: 16253595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.
    Georgieva AM; van Greevenbroek MM; Krauss RM; Brouwers MC; Vermeulen VM; Robertus-Teunissen MG; van der Kallen CJ; de Bruin TW
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):744-9. PubMed ID: 14751815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased lipoprotein lipase activity and increased postprandial concentrations of triglyceride-rich lipoproteins in offspring of elderly survivors of myocardial infarction.
    Lekhal S; Børvik T; Nordøy A; Hansen JB
    Nutr Metab Cardiovasc Dis; 2008 Dec; 18(10):700-6. PubMed ID: 18194851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of postprandial variation in triglyceridemia on low-density lipoprotein particle size.
    Blackburn P; Côté M; Lamarche B; Couillard C; Pascot A; Tremblay A; Bergeron J; Lemieux I; Després JP
    Metabolism; 2003 Nov; 52(11):1379-86. PubMed ID: 14624394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia.
    Kostapanos MS; Milionis HJ; Lagos KG; Rizos CB; Tselepis AD; Elisaf MS
    Eur J Pharmacol; 2008 Aug; 590(1-3):327-32. PubMed ID: 18585701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small dense LDL phenotype is associated with postprandial increases of large VLDL and remnant-like particles in patients with acute myocardial infarction.
    Koba S; Hirano T; Murayama S; Kotani T; Tsunoda F; Iso Y; Ban Y; Kondo T; Suzuki H; Katagiri T
    Atherosclerosis; 2003 Sep; 170(1):131-40. PubMed ID: 12957691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia.
    Masuda D; Nakagawa-Toyama Y; Nakatani K; Inagaki M; Tsubakio-Yamamoto K; Sandoval JC; Ohama T; Nishida M; Ishigami M; Yamashita S
    Eur J Clin Invest; 2009 Aug; 39(8):689-98. PubMed ID: 19490064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low density lipoproteins (LDL) heterogeneity and intravenous fat in neonates.
    Genzel-Boroviczény O; D'Harlingue A; Forte T
    Eur J Med Res; 1996 Apr; 1(7):315-20. PubMed ID: 9364031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies.
    Hayashi T; Hirano T; Yamamoto T; Ito Y; Adachi M
    Metabolism; 2006 Jul; 55(7):879-84. PubMed ID: 16784958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin or fenofibrate on post-prandial lipaemia in type 2 diabetic patients with hyperlipidaemia.
    Iovine C; Lilli S; Gentile A; Patti L; Di Marino L; Cipriano P; Riccardi G; Rivellese AA
    Eur J Clin Invest; 2006 Aug; 36(8):560-5. PubMed ID: 16893378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should we measure routinely the LDL peak particle size?
    Rizzo M; Berneis K
    Int J Cardiol; 2006 Feb; 107(2):166-70. PubMed ID: 16412793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-density lipoprotein (LDL) particle size in healthy prepubertal children: the STRIP study.
    Kaitosaari T; Rönnemaa T; Viikari J; Leino A; Jokinen E; Simell O
    Acta Paediatr; 2006 Dec; 95(12):1668-73. PubMed ID: 17129981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Postprandial changes of blood lipid after ordinary Chinese diet and the influencing factors thereof].
    Fu ZF; Liu ML
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):260-2. PubMed ID: 19552844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colestimide, an anion exchange resin agent, can decrease the number of LDL particles without affecting their size in patients with hyperlipidemia.
    Kishimoto N; Fujii S; Chiba H; Sakuma I; Tsutsui H
    J Cardiol; 2010 Jan; 55(1):65-8. PubMed ID: 20122550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the best predictor of the atherogenic LDL subclass phenotype 'pattern B' in patients with type 2 diabetes mellitus?
    King RI; Florkowski CM; Yeo J; Walmsley TA; Shand BI; Scott RS; George PM
    Ann Clin Biochem; 2011 Mar; 48(Pt 2):166-9. PubMed ID: 21278248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.